Cordis Secured FDA Approval for MYNX CONTROL VENOUS Vascular Closure Device, Expanding Proven MYNX Technology to Mid-Bore Venous Puncture Sites
On July 9, 2024, Cordis, a leading company in cardiovascular and endovascular technology, received FDA approval for its MYNX CONTROL™ VENOUS Vascular Closure Device. This device is approved for use in procedures with access sites ranging from 6F to 12F.
“Using MYNX CONTROL™ VENOUS VCD following ablation procedures, investigators achieved consistent and effective closure, facilitating quick and safe patient ambulation,” said Dr. John Summers, Director of Cardiac Electrophysiology at the SSM Health St. Anthony Hospi...
